4//SEC Filing
Hopman Mark 4
Accession 0001415889-25-002817
CIK 0001674632other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:30 PM ET
Size
15.0 KB
Accession
0001415889-25-002817
Insider Transaction Report
Form 4
Hopman Mark
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-31+17,765→ 17,765 totalExercise: $8.51Exp: 2033-12-31→ Common Stock (17,765 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+37,229→ 37,229 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (37,229 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+83,242→ 83,242 totalExercise: $5.10Exp: 2033-07-26→ Common Stock (83,242 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+47,775→ 47,775 totalExercise: $17.00Exp: 2035-01-28→ Common Stock (47,775 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+39,424→ 39,424 totalExercise: $10.74Exp: 2034-09-29→ Common Stock (39,424 underlying)
Footnotes (6)
- [F1]One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
- [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
- [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
- [F4]The shares subject to this option shall vest in 48 equal monthly installments measured from January 1, 2024.
- [F5]The shares subject to this option shall vest in 48 equal monthly installments measured from September 30, 2024.
- [F6]Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048497
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:30 PM ET
- Size
- 15.0 KB